• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性心血管风险与他汀类药物治疗考量

Cardiovascular Risk and Statin Therapy Considerations in Women.

作者信息

Gheorghe Gina, Toth Peter P, Bungau Simona, Behl Tapan, Ilie Madalina, Pantea Stoian Anca, Bratu Ovidiu Gabriel, Bacalbasa Nicolae, Rus Marius, Diaconu Camelia Cristina

机构信息

Department 5, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

出版信息

Diagnostics (Basel). 2020 Jul 16;10(7):483. doi: 10.3390/diagnostics10070483.

DOI:10.3390/diagnostics10070483
PMID:32708558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7400394/
Abstract

Despite major progress in the prevention and treatment of cardiovascular diseases, women remain an underdiagnosed and insufficiently treated group, with higher hospitalization and death rates compared to men. Obesity, more frequently encountered in women, raises the risk of metabolic syndrome and cardiovascular diseases as women age. There are some differences based on sex regarding the screening, diagnosis, and treatment of dyslipidemia, as it has been observed that women are less frequently prescribed statins and, when they are, they receive lower doses, even after myocardial infarction or coronary revascularization. Real-life data show that, compared to men, women are at higher risk of non-adherence to statin treatment and are more predisposed to discontinue treatment because of side effects. Statin metabolism has some particularities in women, due to a lower glomerular filtration rate, higher body fat percentage, and overall faster statin metabolism. In women of fertile age, before initiating statin treatment, contraception methods should be discussed because statins may have teratogenic effects. Older women have a higher likelihood of polypharmacy, with greater potential for drug interactions when prescribing a statin.

摘要

尽管在心血管疾病的预防和治疗方面取得了重大进展,但女性仍然是诊断不足和治疗不充分的群体,与男性相比,她们的住院率和死亡率更高。肥胖在女性中更为常见,随着女性年龄的增长,肥胖会增加代谢综合征和心血管疾病的风险。在血脂异常的筛查、诊断和治疗方面,存在一些基于性别的差异,因为据观察,女性较少被处方使用他汀类药物,即使使用,剂量也较低,即使在心肌梗死或冠状动脉血运重建后也是如此。实际数据表明,与男性相比,女性不坚持他汀类药物治疗的风险更高,并且由于副作用更倾向于停药。由于肾小球滤过率较低、体脂百分比较高以及他汀类药物代谢总体较快,他汀类药物在女性中的代谢有一些特殊性。在育龄期女性中,在开始他汀类药物治疗之前,应讨论避孕方法,因为他汀类药物可能有致畸作用。老年女性多重用药的可能性更高,在开具他汀类药物处方时发生药物相互作用的可能性更大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf6/7400394/fdb39db85a50/diagnostics-10-00483-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf6/7400394/fdb39db85a50/diagnostics-10-00483-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf6/7400394/fdb39db85a50/diagnostics-10-00483-g001.jpg

相似文献

1
Cardiovascular Risk and Statin Therapy Considerations in Women.女性心血管风险与他汀类药物治疗考量
Diagnostics (Basel). 2020 Jul 16;10(7):483. doi: 10.3390/diagnostics10070483.
2
A systematic review and economic evaluation of statins for the prevention of coronary events.他汀类药物预防冠状动脉事件的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. doi: 10.3310/hta11140.
3
Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.意大利日常临床实践中他汀类药物治疗依从性与非致命性缺血性心脏病风险的回顾性数据库分析结果。
Clin Ther. 2010 Feb;32(2):300-10. doi: 10.1016/j.clinthera.2010.02.004.
4
Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).在低密度脂蛋白胆固醇水平低且高敏C反应蛋白升高的男性和女性中,使用瑞舒伐他汀预防首次心血管事件和死亡的需治疗人数:他汀类药物用于预防的依据:一项评估瑞舒伐他汀的干预试验(JUPITER)
Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):616-23. doi: 10.1161/CIRCOUTCOMES.109.848473. Epub 2009 Sep 22.
5
Statin use prior to first myocardial infarction in contemporary patients: Inefficient and not gender equitable.当代患者首次心肌梗死前使用他汀类药物:效率低下且性别不平等。
Prev Med. 2016 Feb;83:63-9. doi: 10.1016/j.ypmed.2015.12.001. Epub 2015 Dec 11.
6
Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study.在美国他汀类药物使用情况及患者教育差距研究(USAGE)中,关于他汀类药物使用的副作用及态度方面的性别差异。
J Clin Lipidol. 2016 Jul-Aug;10(4):833-841. doi: 10.1016/j.jacl.2016.02.016. Epub 2016 Mar 14.
7
A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention.用于评估在二级心血管预防中起始他汀类药物治疗的患者中他汀类药物诱导的肌病的假设药物基因组学检测的经济价值的离散事件模拟模型。
Mol Diagn Ther. 2018 Apr;22(2):241-254. doi: 10.1007/s40291-018-0323-2.
8
Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States.美国心肌梗死后高强度他汀类药物使用的性别差异。
J Am Coll Cardiol. 2018 Apr 24;71(16):1729-1737. doi: 10.1016/j.jacc.2018.02.032.
9
Renal function and effect of statin therapy on cardiovascular outcomes in patients undergoing coronary revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).接受冠状动脉血运重建(来自 CREDO-Kyoto PCI/CABG 登记研究队列-2)的患者的肾功能和他汀类药物治疗对心血管结局的影响。
Am J Cardiol. 2012 Dec 1;110(11):1568-77. doi: 10.1016/j.amjcard.2012.07.021. Epub 2012 Aug 28.
10
Statin Therapy: Review of Safety and Potential Side Effects.他汀类药物治疗:安全性及潜在副作用综述
Acta Cardiol Sin. 2016 Nov;32(6):631-639. doi: 10.6515/acs20160611a.

引用本文的文献

1
Lipid-lowering statins and polyphenol-based supplementation: a scoping review on drug-food interaction potential.降脂他汀类药物与基于多酚的补充剂:关于药物-食物相互作用潜力的范围综述
Front Pharmacol. 2025 May 30;16:1541871. doi: 10.3389/fphar.2025.1541871. eCollection 2025.
2
Cancer-Therapy-Related Cardiac Dysfunction: Latest Advances in Prevention and Treatment.癌症治疗相关的心脏功能障碍:预防和治疗的最新进展
Life (Basel). 2025 Mar 15;15(3):471. doi: 10.3390/life15030471.
3
Drug-Induced Complete Atrioventricular Block in an Elderly Patient: A Case Report Highlighting Digoxin-Beta Blocker Interactions and a Paradoxical State.

本文引用的文献

1
Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors.关于2型糖尿病与心血管危险因素之间关系的当前数据。
Diagnostics (Basel). 2020 May 16;10(5):314. doi: 10.3390/diagnostics10050314.
2
Low-density lipoprotein cholesterol lowering treatment: the current approach.低密度脂蛋白胆固醇降低治疗:当前方法。
Lipids Health Dis. 2020 May 6;19(1):85. doi: 10.1186/s12944-020-01275-x.
3
Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics.慢性肾脏病患者中的急性冠状动脉综合征:临床与治疗特征。
老年患者药物性完全性房室传导阻滞:1例报告凸显地高辛-β受体阻滞剂相互作用及矛盾状态
Life (Basel). 2025 Jan 31;15(2):215. doi: 10.3390/life15020215.
4
The New Occurrence of Antiphospholipid Syndrome in Severe COVID-19 Cases with Pneumonia and Vascular Thrombosis Could Explain the Post-COVID Syndrome.在患有肺炎和血管血栓形成的重症 COVID-19 病例中抗磷脂综合征的新出现可能解释 COVID 后综合征。
Biomedicines. 2025 Feb 19;13(2):516. doi: 10.3390/biomedicines13020516.
5
Impact of statin use on COVID-19 outcomes in hospitalized patients in Saudi Arabia: a retrospective cohort study.他汀类药物使用对沙特阿拉伯住院患者新冠病毒病结局的影响:一项回顾性队列研究
J Med Life. 2024 Nov;17(11):994-999. doi: 10.25122/jml-2024-0371.
6
Unveiling the Complexities: Exploring Mechanisms of Anthracyclineinduced Cardiotoxicity.揭示复杂性:探索蒽环类药物诱导心脏毒性的机制
Curr Cardiol Rev. 2025;21(2):42-77. doi: 10.2174/011573403X322928241021100631.
7
Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular Disease 2.0.糖尿病、血脂异常和心血管疾病 2.0 中的新型分子
Int J Mol Sci. 2024 Sep 2;25(17):9527. doi: 10.3390/ijms25179527.
8
Implementing care for women with gestational diabetes after delivery-the challenges ahead.产后为妊娠糖尿病女性提供护理——未来的挑战
Front Glob Womens Health. 2024 Aug 16;5:1391213. doi: 10.3389/fgwh.2024.1391213. eCollection 2024.
9
Effect of trace elements and nutrients on diabetes and its complications: a Mendelian randomization study.微量元素和营养素对糖尿病及其并发症的影响:一项孟德尔随机化研究
Front Nutr. 2024 Aug 1;11:1439217. doi: 10.3389/fnut.2024.1439217. eCollection 2024.
10
Exploring galectin-3's role in predicting mild cognitive impairment in type 2 diabetes and its regulation by miRNAs.探索半乳糖凝集素-3在预测2型糖尿病轻度认知障碍中的作用及其受微小RNA的调控。
Front Med (Lausanne). 2024 Jul 31;11:1443133. doi: 10.3389/fmed.2024.1443133. eCollection 2024.
Medicina (Kaunas). 2020 Mar 8;56(3):118. doi: 10.3390/medicina56030118.
4
Dyslipidemia and cardiovascular disease risk among the MASHAD study population.马什哈德研究人群的血脂异常与心血管疾病风险。
Lipids Health Dis. 2020 Mar 16;19(1):42. doi: 10.1186/s12944-020-01204-y.
5
Tobacco Product Use and Cessation Indicators Among Adults - United States, 2018.《2018 年美国成年人烟草制品使用和戒烟指标》
MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1013-1019. doi: 10.15585/mmwr.mm6845a2.
6
Applications of Antioxidants in Metabolic Disorders and Degenerative Diseases: Mechanistic Approach.抗氧化剂在代谢紊乱和退行性疾病中的应用:机制探讨
Oxid Med Cell Longev. 2019 Jul 29;2019:4179676. doi: 10.1155/2019/4179676. eCollection 2019.
7
Sex Differences in the Use of Statins in Community Practice.社区医疗中他汀类药物使用的性别差异。
Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005562. doi: 10.1161/CIRCOUTCOMES.118.005562. Epub 2019 Aug 16.
8
Impediments to clinical application of exercise interventions in the treatment of cardiometabolic disease.运动干预在治疗心脏代谢疾病中的临床应用障碍。
Can Fam Physician. 2019 Mar;65(3):164-170.
9
Effects of gender, age and treatment duration on lipid profile and renal function indices in diabetic patients attending a teaching hospital in South-Western Nigeria.性别、年龄和治疗时长对尼日利亚西南部一家教学医院糖尿病患者血脂谱和肾功能指标的影响。
Afr Health Sci. 2018 Dec;18(4):900-908. doi: 10.4314/ahs.v18i4.8.
10
Diagnosis and Management of Statin Intolerance.他汀类药物不耐受的诊断和管理。
J Atheroscler Thromb. 2019 Mar 1;26(3):207-215. doi: 10.5551/jat.RV17030. Epub 2019 Jan 19.